深圳控股(00604.HK)預期2024財年虧損約10億至12億港元
格隆匯3月21日丨深圳控股(00604.HK)發佈公告,公司預期於2024財年將錄得權益股東應佔未經審覈綜合虧損介於約10億港元至12億港元之間,比對2023財年錄得權益股東應佔經審覈綜合虧損約2.61億港元。
預計權益股東應佔淨虧損增加主要歸因於以下因素的綜合影響:(i)集團於2024財年竣工並交付給買方的物業的毛利率和毛利下降;(ii)2024財年集團分佔合資企業及聯營企業虧損的增加;(iii)集團於2024財年錄得投資物業公允價值變動所產生的虧損(比對2023財年所錄得的收益);及(iv)集團2024財年計提物業及相關資產減值準備增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.